Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) National Cancer Institute (NCI) Global Network for Women's and Children's Health Research Bill and Melinda Gates Foundation John E. Fogarty International Center (FIC) National Center for Complementary and Alternative Medicine (NCCAM) National Institute of Dental and Craniofacial Research (NIDCR) RTI International |
---|---|
Information provided by: | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) |
ClinicalTrials.gov Identifier: | NCT00121368 |
Smoking can contribute to many health problems for mothers and their babies. In developing countries, there is little information about the number of pregnant women that smoke and the reasons why some pregnant women choose to smoke. The purpose of this multi-site tobacco use survey is to obtain information on knowledge, attitudes and behaviors among pregnant women in diverse populations regarding tobacco products.
Condition |
---|
Smoking |
Study Type: | Observational |
Study Design: | Natural History, Cross-Sectional, Convenience Sample, Prospective Study |
Official Title: | Survey on Tobacco Use in the GN Sites |
Estimated Enrollment: | 6000 |
Study Start Date: | February 2004 |
Estimated Study Completion Date: | May 2005 |
Smoking is regarded as one of the few potentially preventable factors associated with low birth weight, very preterm birth and perinatal death. In an effort to determine the prevalence of tobacco use (smoking and smokeless tobacco) and to collect relevant data in support of a potential smoking prevention or cessation intervention, a multi-site tobacco use survey is being conducted in several countries. The survey will be used to obtain information on knowledge, attitudes and behaviors among pregnant women in diverse populations regarding tobacco products.
The primary outcome is tobacco use status during pregnancy. Secondary outcomes include: knowledge and attitudes regarding tobacco products, health hazards of tobacco use and environmental tobacco smoke (ETS) exposure.
Sample size of 750 per country was calculated under the assumptions that the prevalence of tobacco use could be as low as 0.05 with a coefficient of variation of approximately 15% and a prevalence of 0.10 with a CV of approximately 11%.
Ages Eligible for Study: | 18 Years to 45 Years |
Genders Eligible for Study: | Female |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Argentina | |
Buenos Aires, Argentina | |
Brazil | |
Recife, Brazil | |
Congo | |
Kinshasa, Congo | |
Ecuador | |
Quito, Ecuador | |
Guatemala | |
Guatemala City, Guatemala | |
India | |
Belgaum, India | |
India, Orissa | |
Bhubaneswar, Orissa, India | |
Pakistan | |
Karachi, Pakistan | |
Zambia | |
Lusaka, Zambia |
Principal Investigator: | Michele Bloch, MD, PhD | National Cancer Institute (NCI) |
Study ID Numbers: | CP01 Tobacco Use |
Study First Received: | July 15, 2005 |
Last Updated: | April 2, 2007 |
ClinicalTrials.gov Identifier: | NCT00121368 |
Health Authority: | United States: Federal Government |
Global Network Maternal and child health International Women's health Tobacco Smoking Africa |
Latin America South America Guatemala Zambia India Argentina Democratic Republic of the Congo |
Smoking |
Habits |